BIOGEN INC. 10-K filing
Filed 2026-02-06 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0000875045-26-000013
- Form type
- 10-K
- CIK
- 0000875045
- Primary document
- https://www.sec.gov/Archives/edgar/data/875045/000087504526000013/biib-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOGEN INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $9.9B | - | - |
| Cost Of Revenue | $2.4B | - | - |
| Net Income | $1.3B | - | - |
| Eps Basic | 8.83 | - | - |
| Eps Diluted | 8.79 | - | - |
| Total Assets | $29.4B | - | - |
| Total Liabilities | $11.2B | - | - |
| Operating Cash Flow | $2.2B | - | - |
| Capital Expenditures | $153.8M | - | - |